460 results on '"Biegus, Jan"'
Search Results
2. High-intensity care for GDMT titration
3. Role of dietary sodium restriction in chronic heart failure: systematic review and meta-analysis
4. The role of urine chloride in acute heart failure
5. Effectiveness of remote pulmonary artery pressure estimating in heart failure: systematic review and meta-analysis
6. Author Correction: Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure
7. Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure
8. Inotropes and inodilators
9. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk
10. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial
11. Lower Extremity Lymphatic Flow/Drainage Assessment by Indocyanine Green Fluorescent Lymphography in Heart Failure Patients
12. Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
13. Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure
14. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
15. Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic
16. Two-Stage Approach to Cluster Categorical Medical Data
17. Role of the Renal Lymphatic System in Heart Failure
18. Emerging devices for heart failure management
19. Relationship of Vascular Endothelial Growth Factor C, a Lymphangiogenesis Modulator, With Edema Formation, Congestion and Outcomes in Acute Heart Failure
20. Role of Lymphatics in Heart Failure
21. Pressure–Volume Profiles in Heart Failure Across Sexes and Phenotypes
22. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
23. Two-Stage Approach to Cluster Categorical Medical Data
24. Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure
25. Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
26. Preload Reduction Therapies in Heart Failure
27. 2024 update in heart failure
28. Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM‐HF study
29. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
30. Clinical determinants and prognostic significance of hypocapnia in acute heart failure
31. A pilot study on standardised in-hospital education about heart failure conducted during the first days after decompensation.
32. Decongestion in acute heart failure: Is it time to change diuretic‐centred paradigm?
33. Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.
34. Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG‐HF.
35. Application of machine learning in predicting frailty syndrome in patients with heart failure
36. Management of chylopericardium: A novel indocyanine green fluorescence-guided approach to a rare case of cardiac tamponade
37. Prevalence of increased intra-abdominal pressure and its impact on renal function in acute decompensated heart failure: A prospective pilot study
38. Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial
39. Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial
40. Preload Reduction Therapies in Heart Failure
41. Treatment Effects Of Empagliflozin In Hospitalized Heart Failure Patients Across The Range Of Left Ventricular Ejection Fraction - Results From The EMPULSE Trial
42. Pathophysiology of Advanced Heart Failure: What Knowledge Is Needed for Clinical Management?
43. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
44. Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study.
45. Spot urine sodium‐to‐creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure.
46. Tablet-Based Assessment of Cognitive Function Among Heart Failure Patients
47. Empagliflozin in the treatment of heart failure.
48. The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.
49. Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction – Results from the EMPULSE trial.
50. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.